Tamoxifen in Australia: A Doctor’s Guide to Taking Control of Your Breast Cancer Treatment
Written from a doctor’s perspective for Australians over 30 facing hormone receptor-positive breast cancer or at high risk of developing it.
1. Attention: The Fear Behind a Breast Cancer Diagnosis
If you have been diagnosed with hormone receptor-positive breast cancer — or told you are at high risk — it is normal to feel overwhelmed, anxious, and uncertain about the next step. You may be worried about recurrence, side effects, the cost of treatment, and whether you will be able to continue your daily life. The good news is that you are not powerless. Tamoxifen has been a cornerstone of breast cancer treatment for more than 40 years and remains one of the most effective, affordable, and well-studied oral medicines available in Australia.
As a doctor, I often meet patients who have heard frightening stories about side effects or who believe they need complex genetic testing before starting. This article will address those fears directly and help you understand why tamoxifen may be the right choice for you.
2. Interest: How Tamoxifen Works and What You Must Know
How does tamoxifen work?
Tamoxifen belongs to a class of medicines called selective oestrogen receptor modulators (SERMs). Many breast cancer cells rely on oestrogen to grow and multiply. Tamoxifen fits into the oestrogen receptor on breast cancer cells, blocking oestrogen from attaching and stimulating cancer growth. In simple terms, it cuts off the fuel supply that many breast cancers need to survive. In bone tissue, tamoxifen can have a protective effect, which is an added benefit for many women.
For premenopausal and postmenopausal women with early oestrogen receptor-positive (ER+) breast cancer, taking tamoxifen for 5 to 10 years reduces the risk of recurrence by approximately 40–50% and also lowers the chance of developing a new cancer in the opposite breast. These numbers are not trivial — they translate into real lives saved.
What should I discuss with my doctor before starting tamoxifen?
Before you start tamoxifen, an open conversation with your GP or oncologist is essential. Use the table below as a checklist for your appointment.
| Topic |
Why It Matters |
| History of blood clots or stroke |
Tamoxifen can slightly increase the risk of blood clots. Tell your doctor if you or a close family member has had deep vein thrombosis, pulmonary embolism, or stroke. |
| Pregnancy or breastfeeding |
Tamoxifen is not recommended during pregnancy or breastfeeding. Effective contraception is advised during treatment. |
| Liver disease |
Liver function should be monitored, as tamoxifen is processed by the liver. |
| Uterine or endometrial problems |
Tamoxifen can cause thickening of the uterine lining. Report any unusual vaginal bleeding immediately. |
| Other medications and supplements |
Some antidepressants (e.g., paroxetine, fluoxetine), certain antipsychotics, and herbal preparations can affect how tamoxifen is broken down in the body. |
| Eye health |
Rarely, tamoxifen can cause cataracts or retinal changes. Regular eye checks are sensible if you notice vision changes. |
What are the signs of an allergic reaction to tamoxifen?
Allergic reactions to tamoxifen are uncommon but can occur. You should seek urgent medical attention if you experience any of the following:
| Sign |
What to Do |
| Skin rash, hives, or itching |
Stop the medicine and call your doctor immediately. |
| Swelling of the face, lips, tongue, or throat |
This is a medical emergency — call 000 (triple zero) immediately. |
| Difficulty breathing or swallowing |
Seek emergency care without delay. |
| Severe dizziness or fainting |
Lie down and call 000 if symptoms persist. |
Do not ignore these signs. An allergic reaction, while rare, requires prompt action.
Do I need genetic testing before taking tamoxifen?
This is one of the most common questions I hear. The short answer is no, genetic testing is not routinely required before starting tamoxifen in Australia. Tamoxifen is converted in the body to its active form (endoxifen) by an enzyme called CYP2D6. Some people have variations in the CYP2D6 gene that reduce this enzyme’s activity, which theoretically could make tamoxifen less effective. However, large clinical studies have not shown a clear benefit to changing treatment based on CYP2D6 testing for most patients. In Australia, such testing is not a PBS requirement and is not standard practice.
If you are taking strong CYP2D6 inhibitors (such as paroxetine or fluoxetine) or have concerns about drug interactions, your doctor may discuss testing or switching medications. But for the vast majority of people, you can start tamoxifen without genetic testing.
3. Desire: Tamoxifen vs Fulvestrant, Cost, and Practical Concerns
What is the difference between tamoxifen and fulvestrant?
Both tamoxifen and fulvestrant are used to treat hormone receptor-positive breast cancer, but they are not the same. Understanding the difference can help you feel confident in your choice.
| Feature |
Tamoxifen |
Fulvestrant |
| How it is taken |
Oral tablet, once daily |
Intramuscular injection, usually monthly after loading doses |
| Mechanism |
Selective oestrogen receptor modulator (SERM) — blocks oestrogen receptors |
Oestrogen receptor degrader (SERD) — destroys oestrogen receptors |
| Typical use |
Early-stage ER+ breast cancer, metastatic disease, and high-risk prevention |
Metastatic breast cancer in postmenopausal women, often after other hormone therapies |
| Menopausal status |
Can be used in premenopausal and postmenopausal women |
Approved for postmenopausal women |
| Cost |
Low — generic tablets are inexpensive |
High — each injection can cost over $1,000 without subsidy |
| Convenience |
Take at home — no clinic visits required |
Requires visits to a clinic or GP for injections |
For most women with early-stage breast cancer, tamoxifen is the first-line hormone therapy because it is oral, affordable, and backed by decades of evidence. Fulvestrant is generally reserved for advanced disease after other options have been tried. This does not mean fulvestrant is not valuable — it is — but tamoxifen remains the practical, proven workhorse for many patients.
Can I get tamoxifen as a private prescription?
Yes. In Australia, any registered medical practitioner can write a private prescription for tamoxifen. This means you do not need a PBS-subsidised authority script if you are willing to pay the full price out of pocket. Some patients choose a private prescription if they do not meet the PBS criteria for subsidised supply, or if they prefer to avoid potential delays in getting an authority approval. The process is simple: ask your GP or oncologist for a private script, and take it to any community pharmacy.
How much does tamoxifen cost without PBS?
The cost of tamoxifen without PBS subsidy is surprisingly affordable compared with many cancer medicines. Prices vary between pharmacies and brands, but a month’s supply of generic tamoxifen 20 mg tablets typically costs between $30 and $80. This is dramatically lower than fulvestrant injections, which can exceed $1,000 per dose. If you are eligible for PBS subsidy, your cost may be as low as the standard PBS co-payment (around $31.60 for general patients or $7.70 for concession card holders), but even without subsidy, tamoxifen is one of the most cost-effective cancer treatments available.
| Scenario |
Approximate Cost |
| Tamoxifen — private prescription (no PBS subsidy) |
$30 – $80 per month (depending on pharmacy and brand) |
| Tamoxifen — PBS subsidised (if eligible) |
Standard PBS co-payment (e.g., $31.60 general / $7.70 concession) |
| Fulvestrant — private cost per injection |
Often $1,000 – $2,000+ per injection |
Can tamoxifen cause fatigue?
Yes, fatigue is a recognised side effect of tamoxifen. However, it is usually mild and often improves after the first few months. Studies suggest that a minority of patients experience significant tiredness. If fatigue occurs, there are practical strategies to manage it:
- Take tamoxifen at night — this can help you sleep through the period when the drug reaches peak levels.
- Stay physically active — gentle exercise such as walking or yoga can actually boost energy levels.
- Review other medications — sometimes fatigue is worsened by other medicines or underlying conditions like low iron or thyroid problems, which should be checked.
- Prioritise sleep hygiene — consistent sleep routines make a real difference.
If fatigue becomes persistent or disabling, speak to your doctor. There are often ways to adjust your regimen or address contributing factors without abandoning a treatment that is protecting you from cancer recurrence.
4. Action: Your Next Steps
Tamoxifen is not a new, experimental drug. It is a proven, affordable, and convenient option that has helped millions of women around the world. If you have been diagnosed with hormone receptor-positive breast cancer, or if you are at high risk, the most important step is to have an informed conversation with your doctor.
Here is what you can do right now:
- Book an appointment with your GP or oncologist. Bring the checklist above and ask about tamoxifen.
- Ask for a private prescription if you want to proceed without PBS delays or if you are not eligible for subsidy. The cost is likely far lower than you feared.
- Discuss any side effects — including fatigue, hot flushes, or concerns about blood clots — so your doctor can help you manage them early.
- Do not delay because of myths about genetic testing or allergic reactions. These are manageable and uncommon, while the benefit of tamoxifen is substantial.
Taking control of your breast cancer treatment starts with one conversation. Tamoxifen has stood the test of time for a reason: it works, it is easy to take, and it is within financial reach for most Australians. Ask your doctor today whether tamoxifen is right for you — and take the next step towards protecting your future.
Disclaimer: This article is for educational purposes only and does not constitute individual medical advice. Always consult a qualified healthcare professional before starting or changing any treatment.
